Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- CIMC Group Announces 2026 Interim ResultsFinancial Highlights RMB (million) 1H2025 1H2026 1Q2026 2Q2026 Quarter-on-Quarter Change Revenue 76,090 78,913 32,664 46,249 +42% Operating Profit 2,817 1,962 607 1,355 +123% Foreign Exchange Losses 47 803 228 574 The expanded loss is attributable to the expansion of business scale. Pre-FX Loss Operating Profit [1] 2,864 2,764 835 1,929 +131% Profit Before Income Tax 2,798 1,969 615 1,353 +120% Gross Profit 9,643 9,380 3,770 5,611 +49% Gross Profit Margin 12.67% 11.89% 11.54% 12.13% +0.6pct Net Profit 1,764 1,373 412 961 +133% Net Profit Attributable to Shareholders and Other Equity Holders of the Company [2] 1,278 740 209 531 +154% Notes: 1. Pre-FX Loss Operating Profit = Operating Profit + Foreign Exchange Losses 2. Net profit attributable to shareholders and other equity holders of the Company, with interest on perpetual bonds of approximately RMB47.8 million Results Highlights 1. Profitability of energy-related businesses continued to be released, with net profit increasing by RMB1.36 billion: The combined net profit of the offshore engineering segment and the finance and asset management segment (mainly drilling rig leasing) increased by approximately RMB1.339 billion, while that of the energy, chemical and liquid food equipment segment increased by RMB20 million. Among them, the gross profit margin of the offshore engineering segment increased by 10.1 percentage points year-on-year (“YoY”) to 20.9%, with net profit reaching RMB718 million, making it the Company’s largest profit-generating segment. The finance and asset management segment successfully turned losses into profits, with a net profit margin of 9.8%. As at the end of June, total orders on hand amounted to approximately RMB83.6 billion, with production schedules extending to 2030: orders on hand for the offshore engineering and energy, chemical and liquid food equipment segments amounted to US$7.62 billion and RMB31.77 billion, respectively. In particular, CIMC Raffles secured one FPSO and one FLNG EPCIC / EPC general contracting order during the year, making it the first offshore engineering enterprise in China with dual-project general contracting capabilities (EPCIC / EPC). Benefiting from rising demand for increased deepwater oil and gas production, new orders accelerated in the third quarter. 2. Double breakthroughs in modular data center deliveries and orders: The modular data center business recorded explosive growth, with revenue increasing by more than five times YoY. During the Reporting Period, new contracts were signed for 200MW of cloud computing and AI computing power data center projects. 3. Logistics-related businesses consolidated their industry positions, with demand bottoming out and recovering quarter-on-quarter: Core products including standard dry containers, reefer containers, chemical tank containers and semi-trailers maintained their global No. 1 positions. During the Reporting Period, the overall gross profit margin declined due to exchange rate fluctuations and pressure on demand, while demand for containers, road transportation vehicles, airport facilities and logistics equipment, and recycled load bottomed out and recovered quarter-on-quarter. 4. Interest expenses continued to be optimised, with a more robust financial structure: As at the end of Reporting Period, interest-bearing debt amounted to RMB34.8 billion, down RMB6.4 billion from the end of June 2025, with the interest-bearing debt ratio at approximately 20%. Benefiting from the optimisation of financing rates and scale, net interest expenses decreased by approximately RMB218 million YoY during the Reporting Period, and the financial structure continued to be optimised. HONG KONG, August 28, 2026 - China International Marine Containers (Group) Co., Ltd. (“CIMC Group” or the “Group”, stock code: 000039.SZ/02039.HK) is pleased to announce its unaudited interim results for the six months ended 30 June 2026 (the “Reporting Period”). The management of CIMC Group stated that in the first half of 2026, global changes unseen in a century accelerated, geopolitical conflicts reshaped the energy and trade landscape, while global merchandise trade demonstrated resilience amid fluctuations. Against a backdrop of opportunities and challenges, the Group closely followed the main business tone of “focusing on high-quality development and cultivating new growth drivers”, coordinated the reasonable growth of “quantity” and the effective improvement of “quality”, and, leveraging its diversified business portfolio and global operating platform, mitigated fluctuations in individual regions to achieve steady and high-quality development. In the first half of 2026, the Group achieved revenue of RMB78.9 billion and net profit of RMB1.37 billion, while net profit attributable to shareholders and other equity holders of the Company amounted to RMB740 million. During the Reporting Period, domestic revenue accounted for approximately 53.62%, while overseas revenue accounted for approximately 46.38%, maintaining a balanced market structure. To effectively safeguard shareholder value and convey confidence in long-term development, the Company repurchased H Shares amounting to approximately HKD173 million during the first half of 2026, with approximately 19.28 million H Shares repurchased in aggregate. As at the end of June, the Company had completed the implementation of its 2025 H Share repurchase plan. Meanwhile, to further enhance shareholder confidence, the Company announced in July 2026 its plan to repurchase a portion of its H Shares, with the total repurchase amount not exceeding HKD173 million. In respect of A Shares, the Company recently announced a proposal to change the use of the A Shares repurchased in 2023 and cancel such shares and reduce its registered capital, namely, to cancel the 24.65 million A Shares repurchased by the Company in 2023 and correspondingly reduce the registered capital of the Company, thereby adopting multiple measures to safeguard the interests of its investors. Segments Results (RMB million) 1H2026 Business Indicators Revenue % of Total Revenue Gross Profit % of Total Gross Profit Gross Profit Margin Net Profit Container manufacturing 21,920 27.78% 1,827 19.48% 8.34% 272 Road transportation vehicles 10,737 13.61% 1,551 16.53% 14.44% 356 Energy, chemical, and liquid food equipment 13,396 16.98% 1,962 20.92% 14.65% 480 Offshore engineering 7,935 10.06% 1,659 17.69% 20.91% 718 Airport facilities and logistics equipment, fire safety and rescue equipment 3,357 4.25% 706 7.52% 21.03% 71 Logistics services 13,945 17.67% 910 9.70% 6.53% 240 Finance and asset management 1,710 2.17% 287 3.06% 16.77% 167 The above major segments 72,999 92.52% 8,902 94.90% 12.19% 2,304 Core Business Performance 1. In the Logistics Field Container Manufacturing Business: During the Reporting Period, although global trade continued to face adverse factors such as high inflation and geopolitical frictions, the growth of global merchandise trade continued to maintain a certain degree of resilience. According to Container Trades Statistics, global container trade volume increased by approximately 5.2% YoY in the first half of 2026, mainly benefiting from the growth of trade related to the global technology industry. Meanwhile, the low efficiency of container shipping caused by the blockage of the Strait of Hormuz, disruption to the resumption of shipping routes in the Red Sea and port congestion supported demand for containers. During the Reporting Period, the growth in demand for container shipping together with the replacement and renewal requirements for the massive existing container fleet drove a steady rebound in new container sales across the industry in the second quarter, reversing the downward trend seen in the first quarter, while prices also stabilised simultaneously. During the Reporting Period, the Group’s container manufacturing business achieved growth in both production and sales volume. In particular, the accumulated sales volume of dry containers reached 1.1385 million TEUs, representing a YoY increase of approximately 1.12%; meanwhile, benefiting from the bountiful harvest of fresh fruits in South America and the harvest season in the Northern Hemisphere, sales volume of reefer containers reached 108,200 TEUs, representing a YoY increase of approximately 17.61%. During the Reporting Period, the container segment recorded revenue of RMB21.920 billion, representing a YoY increase of 0.85%, and net profit of RMB272 million, mainly affected by the YoY decline in the price of standard containers and exchange rates. Logistics Services Business: During the Reporting Period, the multimodal transport market environment gradually improved, particularly the container shipping market, where freight rates continued to rise since March. During the Reporting Period, the segment achieved revenue of RMB13.945 billion, representing a YoY increase of 2.70%, and net profit of RMB240 million, representing a YoY increase of 18.81%. CIMC Wetrans actively captured the upward trend by deepening customer relationship management, optimising product mix, accelerating overseas expansion and strengthening operational efficiency. During the Reporting Period, the proportion of direct customers in the sea transportation business continued to increase; the port logistics business added route, extra sailing and vessel space agency services for multiple leading shipping companies; the industry logistics business added new cold chain equipment deployment, with cold chain business volume increasing by 14% YoY; the customer structure of the air transportation business continued to be optimised, with business volume increasing by 11% YoY; and the service network of the land transportation business continued to expand. CIMC Wetrans ranked TOP 13 in the 2026 Top 50 Ocean Freight Forwarders list issued by Transport Topics, an authoritative magazine in the global logistics industry, up one place from last year and ranking fifth among Chinese enterprises. Road Transportation Vehicles Business: During the Reporting Period, CIMC Vehicles achieved revenue of RMB10.737 billion, representing a YoY increase of 10.09%, and net profit of RMB356 million. Among them, the global semi-trailer business achieved revenue of RMB7.602 billion, representing a YoY increase of 9.79%. In 2026, CIMC Vehicles continued to extend the production and marketing models of the StarLink Project to more product lines and regions, deepening ecosystem cooperation while improving efficiency and reducing costs. The core production efficiency of the semi-trailer business under the StarLink Project continued to improve, and its domestic market share remained No. 1 for seven consecutive years. In overseas markets, revenue and sales volume in the Global South increased significantly, while gross profit margin remained basically flat due to fluctuations in ocean freight rates; production in the European market recovered, while freight rates and equipment orders in the North American market showed marginal improvement in the second quarter. The market share of core DTB products further increased, with a total of 13,238 truck bodies products products sold. Meanwhile, sales volume of EV-DTB truck bodies products for new energy heavy-duty trucks increased significantly, with deliveries of EV-DTB dump truck and mixer truck truck bodies products continuing to rise. The pure electric tractor and trailer business officially established the world’s first EV-RT offline experience center. Airport Facilities & Logistics Equipment / Fire Safety & Rescue Equipment Business: During the Reporting Period, revenue amounted to RMB3.357 billion, representing a YoY increase of 7.58%; net profit amounted to RMB71 million, representing a YoY decrease of 11.25%, mainly due to exchange rate fluctuations. During the Reporting Period, orders on hand maintained steady growth. The airport facilities and logistics equipment business secured a series of major benchmark orders, including boarding bridge projects worth hundreds of millions of RMB for Paris Airport and Orly Airport in France, as well as bulk orders for A380 catering vehicles in Singapore, further enhancing its global competitiveness. The logistics automation business successfully implemented multiple e-commerce projects in Southeast Asia, and also secured new orders and contracts in newly expanded industries such as State Grid and China Tobacco. The operating results of the fire safety and rescue equipment business showed significant improvement, with the successful securing of a major procurement order for 13 dual-boom water tower fire trucks under the national government subsidy-funded project for hazardous chemical emergency rescue teams. Cumulative new orders reached RMB1.675 billion, achieving steady growth. II. In the Energy Industries Field In respect of the energy, chemical and liquid food equipment business, revenue amounted to RMB13.396 billion, representing a YoY increase of 2.98%; net profit amounted to RMB480 million, representing a YoY increase of 4.35%. Among them, CIMC Enric achieved revenue of RMB12.87 billion, representing a YoY increase of 2.0%; newly signed orders amounted to RMB13.71 billion, representing a significant YoY increase of 27.7%; and as at the end of June, orders on hand amounted to RMB31.77 billion, representing a YoY increase of 8.9%. Specifically, revenue of the clean energy segment grew steadily. Benefiting from expanding demand in areas such as semiconductors and off-grid distributed power generation, the segment delivered electronic specialty gas clean gas cylinders (Y-type cylinders) and specialty tube skid containers in batches, and launched new hydrogen-rich power generation module products. CIMC Enric successfully delivered an integrated LNG liquefaction plant in Indonesia, while implementing its third benchmark steelmaking coke integrated project — the Shougang Shuicheng Steel project in Liupanshui, Guizhou. It also secured newly signed domestic Panzhihua Iron and Steel projects and its first overseas steelmaking coke integrated project with Tsingshan in Indonesia. In the hydrogen energy field, it contributed to the construction of Hong Kong’s first commercial building hydrogen energy charging station and launched China’s first 20-foot Type IV cylinder hydrogen tube skid container. During the Reporting Period, the clean energy segment recorded newly signed orders of RMB10.61 billion, representing a YoY increase of 18.3%, among which newly signed orders for waterborne clean energy reached RMB4.535 billion, representing a significant YoY increase of 40.1%, with shipbuilding orders scheduled through 2029. The chemical and environment segment benefited from the recovery of the chemical industry and high-growth industries such as semiconductors, with demand for tank containers improving, while the medical equipment components business maintained steady growth. As at the end of June 2026, orders on hand increased by 86.8% YoY to RMB1.57 billion. The liquid food segment focused on the non-alcoholic beverage and new consumption sectors, successfully securing and signing multiple turnkey projects, including projects for Japanese breweries and Chinese whisky distilleries. Cumulative newly signed orders reached RMB1.44 billion, representing a strong YoY increase of 108.4%. In respect of the offshore engineering business, benefiting from the cost advantages of deepwater locations, the deepwater offshore engineering market for FPSO/FLNG continued to strengthen. CIMC Raffles, the main operating entity, achieved an important breakthrough in the international high-end offshore engineering general contracting market by signing China’s first FPSO EPCIC general contracting contract, further enhancing its industry competitiveness. During the Reporting Period, revenue amounted to RMB7.935 billion, representing a YoY decrease of 0.98%; net profit amounted to RMB718 million, representing a YoY increase of 155.52%. In terms of market orders, new orders amounted to US$3.2 billion during the Reporting Period, a substantial increase from US$106 million in the same period last year. As at the end of June, CIMC Raffles had cumulative orders on hand of US$7.62 billion, reaching a record high. In terms of project construction and delivery, in January, the PCTC with a capacity of 7,000 vehicles, “NOCC ADRIATIC”, constructed for a Norwegian shipowner, was delivered 70 days ahead of its contractual delivery schedule; in February, the Norse Energi, the world’s largest fully DC wind turbine installation vessel in terms of lifting capacity, completed its seaworthiness delivery; in March, construction commenced on the first vessel of a new generation of seabed rock dumping vessels built for Van Oord, a leading Dutch offshore engineering company; in April, the fore-body module of the P85 hull was slid onto a barge at the Haiyang base, laying a solid foundation for the subsequent successful major assembly of the P85 project; in May, construction of the VLCC tanker officially commenced, entering the substantive construction stage; and in June, the main upper module structure of the project constructed for Golar was successfully capped, marking a key milestone in the project’s construction. In respect of the offshore engineering asset operation and management business, all offshore engineering assets of the Group currently under lease have been operating normally under their respective lease contracts, and the Group continued to provide high-quality services to customers. Benefiting from the successful lease of the Blue Whale No. 1 platform, increased prices upon the renewal of contracts for multiple drilling platforms, and lower operating costs resulting from refined management, operating profit improved during the Reporting Period. During the Reporting Period, the sixth-generation semi-submersible drilling platform “Deepsea Yantai” secured a new drilling contract, injecting momentum into revenue growth; the semi-submersible lifting/life support platform Blue Gretha successfully arrived at its designated operating area to provide high-quality services to clients. Meanwhile, several semi-submersible drilling and life support platforms and other offshore engineering assets of the Group actively pursued new contracts. Future Development and Prospects The management of the Group stated, “2026 is the first year of the ‘15th Five-Year Plan’. The Group will be based on the new development stage, closely follow national policy guidance, and closely focus on ‘focusing on high-quality development and cultivating new growth drivers’. With a more proactive strategic approach, we will cultivate new opportunities and open up new prospects amid complex changes, striving to build ‘a high-quality and respected world-class enterprise’.” About China International Marine Containers (Group) Co., Ltd. The CIMC Group is a world-leading equipment and solution provider in the logistics and energy industries, and its industry clusters mainly cover the logistics and energy fields. In the logistics field, the Group has established a general transportation equipment portfolio covering “sea, land and air”: its container manufacturing business provides key circulation equipment for the container shipping industry; its road transportation vehicles business connects the arteries of land transportation; its airport facilities and logistics equipment/fire safety and rescue equipment businesses expand into aviation hubs and specialised scenarios; its logistics services business provides professional services across the entire-value chain; and its recycled load business provides professional supporting services. In the energy field, the Group is principally engaged in the energy, chemical, and liquid food equipment business and offshore engineering business. Meanwhile, the Group also continuously develops emerging industries and has finance and asset management businesses that serve the Group itself. As a diversified multinational industrial group serving the global market, CIMC has over 300 member enterprises across Asia, North America, Europe, and Australia, with a total of four listed companies, and customers and sales networks covering more than 100 countries and regions worldwide. In 2025, the Group recorded revenue of RMB 156.6 billion, ranking 154th on the 2025 Fortune 500 China list. The Group has maintained the world’s No.1 position for many consecutive years in core products such as standard dry containers, reefer containers, tank containers and semi-trailers. For more information, please visit http://www.cimc.com/.
- Unaudited financial report for the second quarter and 6 months of 2026The main business activity of Trigon Property Development AS is real estate development. As at 30.06.2026, AS Trigon Property Development owned one development project with an area of 13.2 hectares in the City of Pärnu, Estonia. A commercial, industrial and logistics park is planned on this area. The Company’s objective is to find companies willing to bring their business activities (industry, logistics) to the development project area of AS Trigon Property Development in Pärnu, which would add value to the land plots owned by the Company. As the main purpose of the company is to sell existing land plots, investment property was recognized as inventories.
- COSCO SHIPPING Ports Announces 2026 Interim ResultsCompanies: China COSCO ShippingCosco Shipping Holdings Co., Ltd.COSCO SHIPPING Ports Limited (“COSCO SHIPPING Ports” or “CSP” or the “Company”, SEHK: 1199), the world’s leading ports logistics service provider, today announced the interim results of the Company and its subsidiaries (the “Group”) for the 6 months ended 30 June 2026. 2026 Interim Results Highlights - Total throughput increased by 7.9% YoY to 80,157,047 TEU- Equity throughput increased by 7.0% YoY to 24,492,008 TEU- Revenue of the Company increased by 12.3% YoY to US$905,344,000- Gross profit increased by 9.3% YoY to US$239,507,000- Profit attributable to equity holders of the Company increased by 28.5% YoY to US$233,672,000- Declared a first interim dividend of US2.360 cents per share FINANCIAL REVIEW In the first half of 2026, the global shipping market was under dual pressure from route network restructuring and compressed profitability. In the face of these challenges, COSCO SHIPPING Ports has sustained its overall operational resilience by continued deepening of its lean operation management and constant optimisation of its resource allocation and business processes. In the first half of 2026, revenue of the Company increased by 12.3% YoY to US$905.3 million; gross profit increased by 9.3% YoY to US$239.5 million. During the period, the profit attributable to equity holders of the Company greatly increased by 28.5% YoY to US$233.7 million. OPERATIONAL REVIEW Overall PerformanceFor the six months ended 30 June 2026, the Group’s total throughput increased by 7.9% YoY to 80,157,047 TEU (1H2025: 74,295,971 TEU). Total throughput from terminals in which the Group has controlling stake increased by 2.5% YoY to 16,893,574 TEU (1H2025: 16,482,018 TEU), accounting for 21.1% of the Group’s total, and the total throughput from non-controlling terminals increased by 9.4% YoY to 63,263,473 TEU (1H2025: 57,813,953 TEU), accounting for 78.9% of the Group’s total. During the period, the Group’s total equity throughput increased by 7.0% YoY to 24,492,008 TEU (1H2025: 22,879,575 TEU). The equity throughput from terminals in which the Group has controlling stake increased by 2.6% YoY to 9,941,962 TEU (1H2025: 9,691,543 TEU), accounting for 40.6% of the Group’s total, and the equity throughput from non-controlling terminals increased by 10.3% YoY to 14,550,046 TEU (1H2025: 13,188,032 TEU), accounting for 59.4% of the Group’s total. ChinaDuring the period, total throughput of the terminals in China increased by 4.7% YoY to 59,019,217 TEU (1H2025: 56,390,125 TEU) and accounted for 73.6% of the Group’s total throughput. Total equity throughput of terminals in China increased by 4.8% YoY to 16,915,369 TEU (1H2025: 16,136,373 TEU), accounting for 69.1% of the Group’s total equity throughput. Bohai RimDuring the period, total throughput of the Bohai Rim region increased by 6.4% YoY to 27,483,548 TEU (1H2025: 25,835,742 TEU) and accounted for 34.3% of the Group’s total throughput. Total equity throughput of the Bohai Rim region increased by 6.0% YoY to 6,989,982 TEU (1H2025: 6,594,957 TEU) and accounted for 28.5% of the Group’s total equity throughput. Driven by the increasing investment demand in artificial intelligence, exports of high-tech products recorded steady growth, contributing a 4.8% YoY increase in the total throughput of Dalian Container Terminal Co., Ltd. to 2,695,849 TEU (1H2025: 2,572,124 TEU). Yangtze River DeltaDuring the period, total throughput of the Yangtze River Delta region increased by 3.6% YoY to 8,684,169 TEU (1H2025: 8,379,156 TEU) and accounted for 10.8% of the Group’s total throughput. Total equity throughput of the Yangtze River Delta region increased by 6.2% YoY to 2,558,738 TEU (1H2025: 2,408,543 TEU) and accounted for 10.5% of the Group’s total equity throughput. Wuhan CSP Terminal Co., Ltd. (“CSP Wuhan Terminal”) continued to reinforce its competitive edge as a rail-water intermodal transport hub while expanding its Yangtze River feeder network, driving a 34.6% YoY increase in total throughput to 198,577 TEU (1H2025: 147,515 TEU). Southeast Coast and OthersDuring the period, total throughput in the Southeast Coast and Others region decreased by 2.8% YoY to 2,704,696 TEU (1H2025: 2,783,306 TEU) and accounted for 3.4% of the Group’s total throughput. Total equity throughput of Southeast Coast and Others region increased by 3.0% YoY to 2,131,636 TEU (1H2025: 2,070,554 TEU) and accounted for 8.7% of the Group’s total equity throughput. Xiamen Ocean Gate Container Terminal Co., Ltd. continued to strengthen its terminal hub capability, and through the introduction of new route services in the first half of the year, the total throughput increased by 6.8% YoY to 1,366,387 TEU (1H2025: 1,279,547 TEU). Pearl River DeltaDuring the period, total throughput of the Pearl River Delta region increased by 6.5% YoY to 15,577,680 TEU (1H2025: 14,633,421 TEU) and accounted for 19.4% of the Group’s total throughput. Total equity throughput of the Pearl River Delta region increased by 4.6% YoY to 4,237,042 TEU (1H2025: 4,052,292 TEU) and accounted for 17.3% of the Group’s total equity throughput. Driven by trade demand from emerging markets such as Southeast Asia, Guangzhou South China Oceangate Container Terminal Company Limited successfully introduced multiple new shipping routes, driving a 7.4% YoY increase in total throughput to 3,221,826 TEU (1H2025: 3,001,192 TEU). Southwest CoastDuring the period, total throughput of the Southwest Coast region decreased by 4.0% YoY to 4,569,124 TEU (1H2025: 4,758,500 TEU), accounting for 5.7% of the Group’s total throughput. Total equity throughput of the Southwest Coast region decreased by 1.2% YoY to 997,971 TEU (1H2025: 1,010,027 TEU) and accounted for 4.1% of the Group’s total equity throughput. Due to market volatility and changes in cargo mix, total throughput and equity throughput in the Southwest Coast region recorded a YoY decrease. OverseasDuring the period, total throughput in overseas terminals increased by 18.0% YoY to 21,137,830 TEU (1H2025: 17,905,846 TEU) and accounted for 26.4% of the Group’s total throughput. Total equity throughput in overseas terminals increased by 12.4% YoY to 7,576,639 TEU (1H2025: 6,743,202 TEU) and accounted for 30.9% of the Group’s total equity throughput. Piraeus Container Terminal Single Member S.A. (“Piraeus Terminal”) recorded a 2.9% YoY decrease in total throughput to 1,995,150 TEU (1H2025: 2,054,895 TEU), due to softening market demand in the Mediterranean region and adverse weather conditions. CSP Abu Dhabi Terminal L.L.C. (“CSP Abu Dhabi Terminal”) recorded a 44.3% YoY decrease in total throughput to 442,977 TEU (1H2025: 795,758 TEU), affected by geopolitical tensions in the Middle East. COSCO SHIPPING Ports Chancay PERU S.A. (“CSP Chancay Terminal”) has been actively advancing corridor development, deepening synergies with the parent Company’s dual-brand operations, and continuously enhancing its route network layout. In the first half of the year, the terminal achieved a route network of three main lines and five feeder lines, further strengthening its regional connectivity and driving a 68.2% YoY increase in total throughput to 201,773 TEU (1H2025: 119,945 TEU). PROSPECTS Since the beginning of 2026, amid continued deep adjustments to the global economic and trade landscape and rising geopolitical uncertainties, COSCO SHIPPING Ports has remained committed to high-quality development as its overarching priority. The Company has consistently strengthened its core hub layout and global network resilience, while fully leveraging synergies with COSCO SHIPPING Group and the Ocean Alliance. In the first half of the year, the Company’s total throughput and profit attributable to equity holders maintained a YoY increase, with steady improvements in operational quality and efficiency. Looking ahead, international institutions including the World Bank Group and the International Monetary Fund have successively downgraded their global economic growth forecasts. The World Bank projects that global economic growth will moderate from 2.9% in 2025 to 2.5% in 2026, while the IMF has revised its 2026 global growth forecast down to 3%, reflecting the impact of tensions in the Middle East. Changes in the global trade policy environment and fluctuations in energy prices have placed certain pressure on merchandise trade growth. Against this backdrop, the Chinese economy has demonstrated strong resilience. According to statistics from the General Administration of Customs of China, in the first half of the year, the total value of goods imports and exports reached RMB25.47 trillion, representing a YoY increase of 16.9%. Of this, exports amounted to RMB14.73 trillion, a YoY increase of 13.4%; imports totaled RMB10.74 trillion, a YoY increase of 22.1%. China’s trade with emerging markets such as ASEAN and Latin America has continued to deepen, while the share of high-value-added products, including electric vehicles, lithium batteries and photovoltaic products, has steadily increased. These developments have provided strong support for the development of the port industry. In the face of heightened external uncertainties, the Company will remain customer-centric and continue to optimise its global terminal network resource allocation. It will accelerate investment in emerging markets, regional markets and third-country markets, pursuing controlling stakes in strategic hubs while taking minority stakes in key gateway ports as market conditions permit. The Company will also enhance its main and feeder network layout to achieve interconnected and coordinated development across its terminals. It will accelerate the development of port-side logistics parks and supply chain extension services, building integrated resource synergies to provide customers with efficient and convenient port logistics supply chain solutions. Centred on its core port operations, the Company will continue to deepen lean operations and enhance its overall competitiveness. It will reinforce hub port development, raising the service capacity of key hubs including CSP Wuhan Terminal, Piraeus Terminal, CSP Abu Dhabi Terminal and CSP Chancay Terminal. In response to the evolving geopolitical situation in the Middle East, the Company will closely monitor developments, refine contingency plans and information-sharing mechanisms, and continue to optimise feeder network layouts and multi-modal logistics corridors to enhance supply chain resilience. This will enable it to provide more reliable port logistics services to regional customers and effectively address challenges arising from external changes. Under the new landscape of shipping alliances, the Company will strengthen its route network through targeted marketing, actively respond to market changes and route adjustments, continue to introduce new routes and secure additional calls. By improving service quality, it will reinforce its competitive advantage and sustain steady growth in its core business. In terms of green and low-carbon development, the Company will actively cultivate new quality productive forces in the port and shipping industry and lead the sector’s transformation and upgrading. It will continue to advance full-process automation at its terminals, deepen the application of AI and other technologies across all aspects of port operations, and accelerate digitalisation to enable data connectivity and collaborative synergy across systems. The Company will also extend its traditional cargo-handling business towards integrated logistics services, actively developing integrated “shipping + port + logistics” service offerings. With a focus on building green and low-carbon ports, it will further enhance its energy management platform, expand the use of clean energy, and actively participate in the green fuel supply chain to develop full-chain green and low-carbon products, setting industry benchmarks and building new advantages for sustainable development. About COSCO SHIPPING Ports (https://ports.coscoshipping.com) COSCO SHIPPING Ports Limited (Stock Code: 1199) is a leading ports logistics service provider in the world and its terminals portfolio covers the five main port regions and the middle and lower reaches of the Yangtze River in China, Europe, the Mediterranean, the Middle East, Southeast Asia, South America and Africa, etc. As at 30 June 2026, COSCO SHIPPING Ports operated and managed 394 berths at 40 ports globally, of which 245 were for containers. Building on the brand philosophy of “The Ports for ALL”, COSCO SHIPPING Ports has established its corporate mission of “Connecting Different Worlds” and is committed to maintaining a customer-centric approach to continuously improve the service and capacity of its global network and enhance the strategic positioning of key node ports and optimise logistics resource distribution. Leveraging ports as a conduit to connect global shipping services and serve global trade, the Company is dedicated to establishing a platform for mutual benefits and shared successes for all stakeholders involved with a vision of becoming “the leading global port logistics service provider with a customer-oriented focus”. Please visit the Company’s website (https://ports.coscoshipping.com) and the designated website of Hong Kong Exchanges and Clearing Limited (https://www.hkexnews.hk) for 2026 Interim Results Announcement.
- COSCO SHIPPING Ports Announces 2026 Interim ResultsCompanies: China COSCO ShippingCosco Shipping Holdings Co., Ltd.COSCO SHIPPING Ports Limited (“COSCO SHIPPING Ports” or “CSP” or the “Company”, SEHK: 1199), the world’s leading ports logistics service provider, today announced the interim results of the Company and its subsidiaries (the “Group”) for the 6 months ended 30 June 2026. 2026 Interim Results Highlights - Total throughput increased by 7.9% YoY to 80,157,047 TEU - Equity throughput increased by 7.0% YoY to 24,492,008 TEU - Revenue of the Company increased by 12.3% YoY to US$905,344,000 - Gross profit increased by 9.3% YoY to US$239,507,000 - Profit attributable to equity holders of the Company increased by 28.5% YoY to US$233,672,000 - Declared a first interim dividend of US2.360 cents per share FINANCIAL REVIEW In the first half of 2026, the global shipping market was under dual pressure from route network restructuring and compressed profitability. In the face of these challenges, COSCO SHIPPING Ports has sustained its overall operational resilience by continued deepening of its lean operation management and constant optimisation of its resource allocation and business processes. In the first half of 2026, revenue of the Company increased by 12.3% YoY to US$905.3 million; gross profit increased by 9.3% YoY to US$239.5 million. During the period, the profit attributable to equity holders of the Company greatly increased by 28.5% YoY to US$233.7 million. OPERATIONAL REVIEW Overall Performance For the six months ended 30 June 2026, the Group’s total throughput increased by 7.9% YoY to 80,157,047 TEU (1H2025: 74,295,971 TEU). Total throughput from terminals in which the Group has controlling stake increased by 2.5% YoY to 16,893,574 TEU (1H2025: 16,482,018 TEU), accounting for 21.1% of the Group’s total, and the total throughput from non-controlling terminals increased by 9.4% YoY to 63,263,473 TEU (1H2025: 57,813,953 TEU), accounting for 78.9% of the Group’s total. During the period, the Group’s total equity throughput increased by 7.0% YoY to 24,492,008 TEU (1H2025: 22,879,575 TEU). The equity throughput from terminals in which the Group has controlling stake increased by 2.6% YoY to 9,941,962 TEU (1H2025: 9,691,543 TEU), accounting for 40.6% of the Group’s total, and the equity throughput from non-controlling terminals increased by 10.3% YoY to 14,550,046 TEU (1H2025: 13,188,032 TEU), accounting for 59.4% of the Group’s total. China During the period, total throughput of the terminals in China increased by 4.7% YoY to 59,019,217 TEU (1H2025: 56,390,125 TEU) and accounted for 73.6% of the Group’s total throughput. Total equity throughput of terminals in China increased by 4.8% YoY to 16,915,369 TEU (1H2025: 16,136,373 TEU), accounting for 69.1% of the Group’s total equity throughput. Bohai Rim During the period, total throughput of the Bohai Rim region increased by 6.4% YoY to 27,483,548 TEU (1H2025: 25,835,742 TEU) and accounted for 34.3% of the Group’s total throughput. Total equity throughput of the Bohai Rim region increased by 6.0% YoY to 6,989,982 TEU (1H2025: 6,594,957 TEU) and accounted for 28.5% of the Group’s total equity throughput. Driven by the increasing investment demand in artificial intelligence, exports of high-tech products recorded steady growth, contributing a 4.8% YoY increase in the total throughput of Dalian Container Terminal Co., Ltd. to 2,695,849 TEU (1H2025: 2,572,124 TEU). Yangtze River Delta During the period, total throughput of the Yangtze River Delta region increased by 3.6% YoY to 8,684,169 TEU (1H2025: 8,379,156 TEU) and accounted for 10.8% of the Group’s total throughput. Total equity throughput of the Yangtze River Delta region increased by 6.2% YoY to 2,558,738 TEU (1H2025: 2,408,543 TEU) and accounted for 10.5% of the Group’s total equity throughput. Wuhan CSP Terminal Co., Ltd. (“CSP Wuhan Terminal”) continued to reinforce its competitive edge as a rail-water intermodal transport hub while expanding its Yangtze River feeder network, driving a 34.6% YoY increase in total throughput to 198,577 TEU (1H2025: 147,515 TEU). Southeast Coast and Others During the period, total throughput in the Southeast Coast and Others region decreased by 2.8% YoY to 2,704,696 TEU (1H2025: 2,783,306 TEU) and accounted for 3.4% of the Group’s total throughput. Total equity throughput of Southeast Coast and Others region increased by 3.0% YoY to 2,131,636 TEU (1H2025: 2,070,554 TEU) and accounted for 8.7% of the Group’s total equity throughput. Xiamen Ocean Gate Container Terminal Co., Ltd. continued to strengthen its terminal hub capability, and through the introduction of new route services in the first half of the year, the total throughput increased by 6.8% YoY to 1,366,387 TEU (1H2025: 1,279,547 TEU). Pearl River Delta During the period, total throughput of the Pearl River Delta region increased by 6.5% YoY to 15,577,680 TEU (1H2025: 14,633,421 TEU) and accounted for 19.4% of the Group’s total throughput. Total equity throughput of the Pearl River Delta region increased by 4.6% YoY to 4,237,042 TEU (1H2025: 4,052,292 TEU) and accounted for 17.3% of the Group’s total equity throughput. Driven by trade demand from emerging markets such as Southeast Asia, Guangzhou South China Oceangate Container Terminal Company Limited successfully introduced multiple new shipping routes, driving a 7.4% YoY increase in total throughput to 3,221,826 TEU (1H2025: 3,001,192 TEU). Southwest Coast During the period, total throughput of the Southwest Coast region decreased by 4.0% YoY to 4,569,124 TEU (1H2025: 4,758,500 TEU), accounting for 5.7% of the Group’s total throughput. Total equity throughput of the Southwest Coast region decreased by 1.2% YoY to 997,971 TEU (1H2025: 1,010,027 TEU) and accounted for 4.1% of the Group’s total equity throughput. Due to market volatility and changes in cargo mix, total throughput and equity throughput in the Southwest Coast region recorded a YoY decrease. Overseas During the period, total throughput in overseas terminals increased by 18.0% YoY to 21,137,830 TEU (1H2025: 17,905,846 TEU) and accounted for 26.4% of the Group’s total throughput. Total equity throughput in overseas terminals increased by 12.4% YoY to 7,576,639 TEU (1H2025: 6,743,202 TEU) and accounted for 30.9% of the Group’s total equity throughput. Piraeus Container Terminal Single Member S.A. (“Piraeus Terminal”) recorded a 2.9% YoY decrease in total throughput to 1,995,150 TEU (1H2025: 2,054,895 TEU), due to softening market demand in the Mediterranean region and adverse weather conditions. CSP Abu Dhabi Terminal L.L.C. (“CSP Abu Dhabi Terminal”) recorded a 44.3% YoY decrease in total throughput to 442,977 TEU (1H2025: 795,758 TEU), affected by geopolitical tensions in the Middle East. COSCO SHIPPING Ports Chancay PERU S.A. (“CSP Chancay Terminal”) has been actively advancing corridor development, deepening synergies with the parent Company’s dual-brand operations, and continuously enhancing its route network layout. In the first half of the year, the terminal achieved a route network of three main lines and five feeder lines, further strengthening its regional connectivity and driving a 68.2% YoY increase in total throughput to 201,773 TEU (1H2025: 119,945 TEU). PROSPECTS Since the beginning of 2026, amid continued deep adjustments to the global economic and trade landscape and rising geopolitical uncertainties, COSCO SHIPPING Ports has remained committed to high-quality development as its overarching priority. The Company has consistently strengthened its core hub layout and global network resilience, while fully leveraging synergies with COSCO SHIPPING Group and the Ocean Alliance. In the first half of the year, the Company’s total throughput and profit attributable to equity holders maintained a YoY increase, with steady improvements in operational quality and efficiency. Looking ahead, international institutions including the World Bank Group and the International Monetary Fund have successively downgraded their global economic growth forecasts. The World Bank projects that global economic growth will moderate from 2.9% in 2025 to 2.5% in 2026, while the IMF has revised its 2026 global growth forecast down to 3%, reflecting the impact of tensions in the Middle East. Changes in the global trade policy environment and fluctuations in energy prices have placed certain pressure on merchandise trade growth. Against this backdrop, the Chinese economy has demonstrated strong resilience. According to statistics from the General Administration of Customs of China, in the first half of the year, the total value of goods imports and exports reached RMB25.47 trillion, representing a YoY increase of 16.9%. Of this, exports amounted to RMB14.73 trillion, a YoY increase of 13.4%; imports totaled RMB10.74 trillion, a YoY increase of 22.1%. China’s trade with emerging markets such as ASEAN and Latin America has continued to deepen, while the share of high-value-added products, including electric vehicles, lithium batteries and photovoltaic products, has steadily increased. These developments have provided strong support for the development of the port industry. In the face of heightened external uncertainties, the Company will remain customer-centric and continue to optimise its global terminal network resource allocation. It will accelerate investment in emerging markets, regional markets and third-country markets, pursuing controlling stakes in strategic hubs while taking minority stakes in key gateway ports as market conditions permit. The Company will also enhance its main and feeder network layout to achieve interconnected and coordinated development across its terminals. It will accelerate the development of port-side logistics parks and supply chain extension services, building integrated resource synergies to provide customers with efficient and convenient port logistics supply chain solutions. Centred on its core port operations, the Company will continue to deepen lean operations and enhance its overall competitiveness. It will reinforce hub port development, raising the service capacity of key hubs including CSP Wuhan Terminal, Piraeus Terminal, CSP Abu Dhabi Terminal and CSP Chancay Terminal. In response to the evolving geopolitical situation in the Middle East, the Company will closely monitor developments, refine contingency plans and information-sharing mechanisms, and continue to optimise feeder network layouts and multi-modal logistics corridors to enhance supply chain resilience. This will enable it to provide more reliable port logistics services to regional customers and effectively address challenges arising from external changes. Under the new landscape of shipping alliances, the Company will strengthen its route network through targeted marketing, actively respond to market changes and route adjustments, continue to introduce new routes and secure additional calls. By improving service quality, it will reinforce its competitive advantage and sustain steady growth in its core business. In terms of green and low-carbon development, the Company will actively cultivate new quality productive forces in the port and shipping industry and lead the sector’s transformation and upgrading. It will continue to advance full-process automation at its terminals, deepen the application of AI and other technologies across all aspects of port operations, and accelerate digitalisation to enable data connectivity and collaborative synergy across systems. The Company will also extend its traditional cargo-handling business towards integrated logistics services, actively developing integrated “shipping + port + logistics” service offerings. With a focus on building green and low-carbon ports, it will further enhance its energy management platform, expand the use of clean energy, and actively participate in the green fuel supply chain to develop full-chain green and low-carbon products, setting industry benchmarks and building new advantages for sustainable development. About COSCO SHIPPING Ports (https://ports.coscoshipping.com) COSCO SHIPPING Ports Limited (Stock Code: 1199) is a leading ports logistics service provider in the world and its terminals portfolio covers the five main port regions and the middle and lower reaches of the Yangtze River in China, Europe, the Mediterranean, the Middle East, Southeast Asia, South America and Africa, etc. As at 30 June 2026, COSCO SHIPPING Ports operated and managed 394 berths at 40 ports globally, of which 245 were for containers. Building on the brand philosophy of “The Ports for ALL”, COSCO SHIPPING Ports has established its corporate mission of “Connecting Different Worlds” and is committed to maintaining a customer-centric approach to continuously improve the service and capacity of its global network and enhance the strategic positioning of key node ports and optimise logistics resource distribution. Leveraging ports as a conduit to connect global shipping services and serve global trade, the Company is dedicated to establishing a platform for mutual benefits and shared successes for all stakeholders involved with a vision of becoming “the leading global port logistics service provider with a customer-oriented focus”. Please visit the Company’s website (https://ports.coscoshipping.com) and the designated website of Hong Kong Exchanges and Clearing Limited (https://www.hkexnews.hk) for 2026 Interim Results Announcement.
- Fosun International Delivers 160.3% YoY Profit Growth in 1H2026Companies: Fosun International LimitedOn the evening of 27 August, Fosun International announced its 2026 interim results. During the Reporting Period, its total revenue reached RMB86.96 billion; profit attributable to owners of the parent reached RMB1.72 billion, representing a year-on-year increase of 160.3%; overseas revenue reached RMB49.16 billion, with its share of total revenue rising to 56.5%; total debt to total capital ratio decreased to 55.7%. These figures show that Fosun’s results fall in the upper-middle range of the Company’s profit alert (profit attributable to owners of the parent is expected to range from approximately RMB1.5 billion to RMB1.8 billion, representing a year-on-year increase of approximately 127% to 172%) issued on 29 July. This marks Fosun’s return to a growth trajectory following the completion of a systematic realignment of “repairing the roof on a sunny day”. Over the past few years, Fosun has taken a rather unconventional path. Since 2022, in response to the severe market disruption caused by the pandemic, the Company has advanced its business streamlining and core business-focused strategy, divesting assets and businesses and generating cumulative cash proceeds of approximately RMB75 billion. In March 2026, pursuant to the principle of prudence, Fosun made one-off, non-cash impairment provisions and value revaluations on certain real estate projects with impairment indicators and goodwill and intangible assets of certain non-core business segments. The move drew considerable market attention at the time. At the Company’s 2025 annual results presentation at the end of March, Guo Guangchang, Chairman of Fosun International, explained, “This is about ‘repairing the roof on a sunny day’, allowing Fosun to focus its resources and efforts more effectively on core, high-growth areas.” The market has now responded to Fosun’s “repairing the roof on a sunny day” initiative. From the announcement of profit alert in early March to 25 August, before its interim results announcement, Fosun’s share price rose sharply from HKD3.6 to HKD5.41, representing an increase of more than 50%. The market has gradually recognized and priced in the Group’s “risk clearance” efforts. More importantly, the earnings growth driven by the Group’s businesses has begun to materialize. At the 2026 interim results presentation held in Hong Kong on 28 August, Guo Guangchang said: “The strong results recovery we delivered in the first half of the year reflects the outcome of the strategic adjustments we have made over the past few years. Our ‘repairing the roof on a sunny day’ strategy has paid off, allowing us to put historical burdens behind us. These results mark the beginning of Fosun’s continued progress along a trajectory of steady growth.” Solid Core Businesses, with Pharmaceuticals and Insurance Posting Strong Results First, let us look at Fosun’s core businesses. In the first half of 2026, its four core businesses — Fosun Pharma, Yuyuan, Fosun Insurance Portugal (Fidelidade), and the Tourism segment — generated a total revenue of RMB63.88 billion, accounting for 73.5% of the Group’s total revenue, further demonstrating the results of its core business-focused strategy. Among them, the pharmaceutical and insurance segments delivered particularly strong performance. In the first half of the year, Fosun Pharma achieved operating revenue of RMB20.377 billion. Revenue from innovative drugs recorded a year-on-year increase of 13.84%, with their contribution to pharmaceutical business revenue rising to 33.35%, establishing innovative drugs as a key growth driver. Its innovative biopharmaceutical platform, Henlius, reported revenue of RMB3.5882 billion, representing a year-on-year increase of 27.3%, while net profit amounted to RMB430.4 million, up 10.3% year-on-year, sustaining growth momentum in revenue and profit. Commercialization of innovative drugs continued to gain traction. During the Reporting Period, Fosun Pharma had a total of 20 indications of 7 innovative drugs approved for launch both domestically and overseas. With their revenue share on a steady rise, innovative drugs have become the main growth engine driving the pharmaceutical business forward. The insurance segment delivered a stellar performance, with Fosun’s domestic and overseas insurance companies all posting broad-based improvements. Fidelidade’s overall market share in Portugal reached 30.1%, and its international business accounted for 26.7% of its consolidated total business. In the first half of the year, Fidelidade recorded net profit attributable to owners of the parent of EUR165 million, up 23.8% year-on-year, maintaining steady growth. In Chinese mainland, Pramerica Fosun Life Insurance recorded gross written premiums of RMB8.38 billion in the first half of 2026, up 52.2% year-on-year. Net profit reached RMB780 million, representing a year-on-year increase of 270% and exceeding its net profit for the full year of 2025. Fosun United Health Insurance reported a 36.2% year-on-year increase in revenue and net profit of RMB572 million. Peak Reinsurance’s reinsurance revenue and gross written premiums increased by 25% and 11.8% year-on- year, respectively, while net profit after tax reached USD89.70 million. In April 2026, Moody’s upgraded Peak Re’s rating from Baa1 to A3, with a “stable” outlook. Guo Guangchang said at the results presentation: “Integrating our insurance business with industries in which we have established competitive advantages has been a strategic priority for Fosun for over three decades — a critical linkage we have long sought to unlock. I believe we have now achieved it. This integration will significantly strengthen our industrial operational capabilities and future profitability, providing sustained momentum for Fosun’s development.” “Successfully navigating another cycle” is how the market has described Fosun’s latest round of adjustments. A closer look reveals how Fosun has successfully navigated the cycle. On the one hand, the Group has continued to streamline its business to generate cash proceeds. In the first half of the year, the Group generated proceeds equivalent to more than RMB12.0 billion from the divestment of non-strategic and non-core assets. Its total debt to total capital ratio was reduced to 55.7%, while its cash, bank balances and term deposits amounted to RMB61.214 billion. On the other hand, the innovation and globalization strategy that the Group has been pursuing for years has entered a value-realization phase, serving as the core engine driving profit recovery. Integrated Innovation Strategy Bears Fruit Since innovative drugs took off in the domestic market in 2025, Fosun has repeatedly broken into the spotlight, with multiple innovative drug business development (BD) drawing significant market attention. In fact, as the saying goes, “One minute on stage takes ten years of hard work off stage”. This series of innovation achievements is the result of Fosun’s forward-looking innovation strategy established nearly two decades ago. Notably, for more than a decade, Fosun has built a globally integrated innovation system across its core business areas, combining “independent R&D + investment incubation + ecosystem collaboration”, and has consistently made substantial investments in technology innovation. In the first half of this year alone, investment in technology innovation reached RMB4.2 billion, representing a year-on-year increase of 16.7%. In the first half of this year, Fosun saw a series of innovations come to fruition. HANSIZHUANG, independently developed by Henlius, received approval from the National Medical Products Administration (NMPA) for its perioperative indication in gastric cancer, pioneering a postoperative “chemo-sparing” regimen and making it the world’s first and only anti-PD-1 monoclonal antibody approved for this indication. Its core pipeline asset, HLX43, as a potential best-in-class (BIC) broad-spectrum anti-tumor PD-L1 ADC, has demonstrated preliminary clinical efficacy characterized by high efficacy and low toxicity across multiple solid tumors, including non-small cell lung cancer (NSCLC), with over 1,500 patients enrolled globally. To date, Henlius has 10 products approved in over 60 countries and regions, and has benefited over 1.1 million patients. In addition, FUMAINING (luvoxmetinib tablets), independently developed by Fosun Pharma, was approved for the treatment of paediatric and adolescent patients with relapsed or refractory Langerhans cell histiocytosis (LCH), continuing to fill the gap in the treatment of rare diseases. In terms of neurodegenerative diseases, Fosun Pharma expanded its global collaboration with AriBio on AR1001, extending its rights to develop and commercialize the product to key markets including the U.S., Europe and Japan. Meanwhile, post-marketing confirmatory clinical trials for sodium oligomannate capsules have progressed steadily, with more than 1,000 patients enrolled as of 31 July 2026. In addition, HT001, an oral NLRP3 inhibitor for the treatment of Parkinson’s disease in-licensed by Hengtai Bio, an investee and incubated company of Fosun Pharma, commenced its Phase I clinical trial in Australia. Fosun’s innovation achievements demonstrate the forward-looking nature of its innovation strategy and its ability to identify the right opportunities in R&D. As Guo Guangchang remarked at the results presentation, through years of effort, Fosun has built globally integrated innovation capabilities rooted in China. This distinctive strength of Fosun is expected to create greater value for all in the years ahead. “Fosun has never pursued innovation behind closed doors. Instead, we leverage our resource-integration capabilities and a global perspective to drive smart innovation, bringing together the best technologies, teams and supply chains from around the world to solve real problems. This is how we unlock vast market potential,” said Guo Guangchang. Unlocking Value through Global Operations Globalization has been another forward-looking strategic move for Fosun. Since its listing in Hong Kong in 2007, when many Chinese companies were still focused primarily on their domestic markets, Fosun had already begun expanding overseas ahead of its peers. Nearly two decades later, as a growing number of Chinese companies embrace the view that they must go global or risk being left behind, and seek to capture overseas markets by taking their products overseas, Fosun has already established a profound business presence in more than 40 countries and regions. With local teams operating overseas, it has successfully operated a number of companies within the Fosun ecosystem. “Global operations” have become a defining feature of Fosun’s globalization strategy and a core engine underpinning the development of its businesses. Guo Guangchang said at the interim results presentation that Fosun continues to strengthen its global operational capabilities. On the one hand, it is helping Chinese products and services enter overseas markets. On the other hand, it is introducing high-quality products and services from around the world into China. Drawing on the global resource-mobilization capabilities it has built over the years, Fosun is able to identify high-quality projects and technologies worldwide and rapidly mobilize the resources needed to advance them. In the first half of 2026, Fosun’s overseas revenue reached RMB49.16 billion, accounting for 56.5% of total revenue, up 3 percentage points as compared to the same period of 2025 and marking a record high in the proportion of overseas revenue. In the field of pharmaceuticals and healthcare, Fosun made substantial progress in the global expansion of innovative drugs and commercial business development. Henlius’ HANSIZHUANG was approved for three new indications in the European Union (EU), while HLX11 (pertuzumab injection) was approved in the EU and HLX14 (denosumab injection) was approved in Canada. At the beginning of 2026, Fosun Pharma entered into a strategic partnership with Eisai for HANSIZHUANG, with an aggregate potential consideration exceeding USD300 million, underscoring how the global value of Chinese innovative drugs is being repriced by international markets. In the first half of the year, Yuyuan generated revenue of RMB532 million in Hong Kong SAR and Macau SAR in the first half of 2026, representing a year-on-year increase of 285.83%, while revenue from the Japanese market reached RMB306 million, representing a year-on-year increase of 6.09%. Laomiao has 15 stores in Hong Kong SAR, Macau SAR, overseas markets and duty-free channels. Club Med has also continued to expand its global footprint, with Club Med Urban Oasis Hangzhou Longwu already open and Club Med South Africa Beach & Safari now in soft opening. Leveraging Fosun’s global ecosystem, Fidelidade in the insurance segment has expanded its business from Portugal to Portuguese-speaking countries and markets across Europe, Latin America, and Africa. Its international business now accounts for 26.7% of its consolidated total business, with continued growth in Portuguese-speaking countries. Meanwhile, Peak Reinsurance has maintained steady growth thanks to its global business footprint. The guiding principle behind Fosun’s globalization strategy is “Combining Global Resources with China’s Capabilities”, deeply integrating China’s manufacturing capabilities, service capabilities, and innovation dividends, with global markets. Starting with leveraging China’s growth momentum to establish its business presence, and progressing to a two-way engagement of “mutual empowerment between China and the world”, Fosun has now entered the 3.0 phase of “global organization + local operations”. In this phase, Fosun “truly operates with a global perspective”, having developed the ability to foster cross-regional, cross-cultural, and cross-organizational synergies within its business ecosystem and support the continued growth of its overseas revenue. At the interim results presentation held on 28 August, Guo Guangchang said: “Fosun’s future development goal is to ‘spur the horse to full speed’. We have already positioned ourselves on a trajectory of steady growth. Going forward, we will continue to advance innovation-driven and global development in industries where we have established competitive advantages, building on our momentum and accelerating further.”
- Commercial Vehicle Clutches Market Outlook 2026-2030 - Featuring Profiles of Leading Companies Eaton, ZF Friedrichshafen, and ValeoCompanies: ZF Friedrichshafen AGValeoE-commerce logistics, heavy-duty fleets and electrification are driving demand for durable high-torque clutches, advanced friction materials, automated systems and remanufacturing.
- Clinical Trial Supply Market (2026-2031) - Growth Driven by Increasing Clinical Trial ActivityMulticountry and decentralized trials are driving demand for cross-border logistics, home delivery, cold chains, flexible packaging, comparator sourcing and AI-led inventory tools.
- Fosun International Delivers 160.3% YoY Profit Growth in 1H2026Companies: Fosun International LimitedOn the evening of 27 August, Fosun International announced its 2026 interim results. During the Reporting Period, its total revenue reached RMB86.96 billion; profit attributable to owners of the parent reached RMB1.72 billion, representing a year-on-year increase of 160.3%; overseas revenue reached RMB49.16 billion, with its share of total revenue rising to 56.5%; total debt to total capital ratio decreased to 55.7%. These figures show that Fosun’s results fall in the upper-middle range of the Company’s profit alert (profit attributable to owners of the parent is expected to range from approximately RMB1.5 billion to RMB1.8 billion, representing a year-on-year increase of approximately 127% to 172%) issued on 29 July. This marks Fosun’s return to a growth trajectory following the completion of a systematic realignment of “repairing the roof on a sunny day”. Over the past few years, Fosun has taken a rather unconventional path. Since 2022, in response to the severe market disruption caused by the pandemic, the Company has advanced its business streamlining and core business-focused strategy, divesting assets and businesses and generating cumulative cash proceeds of approximately RMB75 billion. In March 2026, pursuant to the principle of prudence, Fosun made one-off, non-cash impairment provisions and value revaluations on certain real estate projects with impairment indicators and goodwill and intangible assets of certain non-core business segments. The move drew considerable market attention at the time. At the Company’s 2025 annual results presentation at the end of March, Guo Guangchang, Chairman of Fosun International, explained, “This is about ‘repairing the roof on a sunny day’, allowing Fosun to focus its resources and efforts more effectively on core, high-growth areas.” The market has now responded to Fosun’s “repairing the roof on a sunny day” initiative. From the announcement of profit alert in early March to 25 August, before its interim results announcement, Fosun’s share price rose sharply from HKD3.6 to HKD5.41, representing an increase of more than 50%. The market has gradually recognized and priced in the Group’s “risk clearance” efforts. More importantly, the earnings growth driven by the Group’s businesses has begun to materialize. At the 2026 interim results presentation held in Hong Kong on 28 August, Guo Guangchang said: “The strong results recovery we delivered in the first half of the year reflects the outcome of the strategic adjustments we have made over the past few years. Our ‘repairing the roof on a sunny day’ strategy has paid off, allowing us to put historical burdens behind us. These results mark the beginning of Fosun’s continued progress along a trajectory of steady growth.” Solid Core Businesses, with Pharmaceuticals and Insurance Posting Strong Results First, let us look at Fosun’s core businesses. In the first half of 2026, its four core businesses — Fosun Pharma, Yuyuan, Fosun Insurance Portugal (Fidelidade), and the Tourism segment — generated a total revenue of RMB63.88 billion, accounting for 73.5% of the Group’s total revenue, further demonstrating the results of its core business-focused strategy. Among them, the pharmaceutical and insurance segments delivered particularly strong performance. In the first half of the year, Fosun Pharma achieved operating revenue of RMB20.377 billion. Revenue from innovative drugs recorded a year-on-year increase of 13.84%, with their contribution to pharmaceutical business revenue rising to 33.35%, establishing innovative drugs as a key growth driver. Its innovative biopharmaceutical platform, Henlius, reported revenue of RMB3.5882 billion, representing a year-on-year increase of 27.3%, while net profit amounted to RMB430.4 million, up 10.3% year-on-year, sustaining growth momentum in revenue and profit. Commercialization of innovative drugs continued to gain traction. During the Reporting Period, Fosun Pharma had a total of 20 indications of 7 innovative drugs approved for launch both domestically and overseas. With their revenue share on a steady rise, innovative drugs have become the main growth engine driving the pharmaceutical business forward. The insurance segment delivered a stellar performance, with Fosun’s domestic and overseas insurance companies all posting broad-based improvements. Fidelidade’s overall market share in Portugal reached 30.1%, and its international business accounted for 26.7% of its consolidated total business. In the first half of the year, Fidelidade recorded net profit attributable to owners of the parent of EUR165 million, up 23.8% year-on-year, maintaining steady growth. In Chinese mainland, Pramerica Fosun Life Insurance recorded gross written premiums of RMB8.38 billion in the first half of 2026, up 52.2% year-on-year. Net profit reached RMB780 million, representing a year-on-year increase of 270% and exceeding its net profit for the full year of 2025. Fosun United Health Insurance reported a 36.2% year-on-year increase in revenue and net profit of RMB572 million. Peak Reinsurance’s reinsurance revenue and gross written premiums increased by 25% and 11.8% year-on- year, respectively, while net profit after tax reached USD89.70 million. In April 2026, Moody’s upgraded Peak Re’s rating from Baa1 to A3, with a “stable” outlook. Guo Guangchang said at the results presentation: “Integrating our insurance business with industries in which we have established competitive advantages has been a strategic priority for Fosun for over three decades — a critical linkage we have long sought to unlock. I believe we have now achieved it. This integration will significantly strengthen our industrial operational capabilities and future profitability, providing sustained momentum for Fosun’s development.” “Successfully navigating another cycle” is how the market has described Fosun’s latest round of adjustments. A closer look reveals how Fosun has successfully navigated the cycle. On the one hand, the Group has continued to streamline its business to generate cash proceeds. In the first half of the year, the Group generated proceeds equivalent to more than RMB12.0 billion from the divestment of non-strategic and non-core assets. Its total debt to total capital ratio was reduced to 55.7%, while its cash, bank balances and term deposits amounted to RMB61.214 billion. On the other hand, the innovation and globalization strategy that the Group has been pursuing for years has entered a value-realization phase, serving as the core engine driving profit recovery. Integrated Innovation Strategy Bears Fruit Since innovative drugs took off in the domestic market in 2025, Fosun has repeatedly broken into the spotlight, with multiple innovative drug business development (BD) drawing significant market attention. In fact, as the saying goes, “One minute on stage takes ten years of hard work off stage”. This series of innovation achievements is the result of Fosun’s forward-looking innovation strategy established nearly two decades ago. Notably, for more than a decade, Fosun has built a globally integrated innovation system across its core business areas, combining “independent R&D + investment incubation + ecosystem collaboration”, and has consistently made substantial investments in technology innovation. In the first half of this year alone, investment in technology innovation reached RMB4.2 billion, representing a year-on-year increase of 16.7%. In the first half of this year, Fosun saw a series of innovations come to fruition. HANSIZHUANG, independently developed by Henlius, received approval from the National Medical Products Administration (NMPA) for its perioperative indication in gastric cancer, pioneering a postoperative “chemo-sparing” regimen and making it the world’s first and only anti-PD-1 monoclonal antibody approved for this indication. Its core pipeline asset, HLX43, as a potential best-in-class (BIC) broad-spectrum anti-tumor PD-L1 ADC, has demonstrated preliminary clinical efficacy characterized by high efficacy and low toxicity across multiple solid tumors, including non-small cell lung cancer (NSCLC), with over 1,500 patients enrolled globally. To date, Henlius has 10 products approved in over 60 countries and regions, and has benefited over 1.1 million patients. In addition, FUMAINING (luvoxmetinib tablets), independently developed by Fosun Pharma, was approved for the treatment of paediatric and adolescent patients with relapsed or refractory Langerhans cell histiocytosis (LCH), continuing to fill the gap in the treatment of rare diseases. In terms of neurodegenerative diseases, Fosun Pharma expanded its global collaboration with AriBio on AR1001, extending its rights to develop and commercialize the product to key markets including the U.S., Europe and Japan. Meanwhile, post-marketing confirmatory clinical trials for sodium oligomannate capsules have progressed steadily, with more than 1,000 patients enrolled as of 31 July 2026. In addition, HT001, an oral NLRP3 inhibitor for the treatment of Parkinson’s disease in-licensed by Hengtai Bio, an investee and incubated company of Fosun Pharma, commenced its Phase I clinical trial in Australia. Fosun’s innovation achievements demonstrate the forward-looking nature of its innovation strategy and its ability to identify the right opportunities in R&D. As Guo Guangchang remarked at the results presentation, through years of effort, Fosun has built globally integrated innovation capabilities rooted in China. This distinctive strength of Fosun is expected to create greater value for all in the years ahead. “Fosun has never pursued innovation behind closed doors. Instead, we leverage our resource-integration capabilities and a global perspective to drive smart innovation, bringing together the best technologies, teams and supply chains from around the world to solve real problems. This is how we unlock vast market potential,” said Guo Guangchang. Unlocking Value through Global Operations Globalization has been another forward-looking strategic move for Fosun. Since its listing in Hong Kong in 2007, when many Chinese companies were still focused primarily on their domestic markets, Fosun had already begun expanding overseas ahead of its peers. Nearly two decades later, as a growing number of Chinese companies embrace the view that they must go global or risk being left behind, and seek to capture overseas markets by taking their products overseas, Fosun has already established a profound business presence in more than 40 countries and regions. With local teams operating overseas, it has successfully operated a number of companies within the Fosun ecosystem. “Global operations” have become a defining feature of Fosun’s globalization strategy and a core engine underpinning the development of its businesses. Guo Guangchang said at the interim results presentation that Fosun continues to strengthen its global operational capabilities. On the one hand, it is helping Chinese products and services enter overseas markets. On the other hand, it is introducing high-quality products and services from around the world into China. Drawing on the global resource-mobilization capabilities it has built over the years, Fosun is able to identify high-quality projects and technologies worldwide and rapidly mobilize the resources needed to advance them. In the first half of 2026, Fosun’s overseas revenue reached RMB49.16 billion, accounting for 56.5% of total revenue, up 3 percentage points as compared to the same period of 2025 and marking a record high in the proportion of overseas revenue. In the field of pharmaceuticals and healthcare, Fosun made substantial progress in the global expansion of innovative drugs and commercial business development. Henlius’ HANSIZHUANG was approved for three new indications in the European Union (EU), while HLX11 (pertuzumab injection) was approved in the EU and HLX14 (denosumab injection) was approved in Canada. At the beginning of 2026, Fosun Pharma entered into a strategic partnership with Eisai for HANSIZHUANG, with an aggregate potential consideration exceeding USD300 million, underscoring how the global value of Chinese innovative drugs is being repriced by international markets. In the first half of the year, Yuyuan generated revenue of RMB532 million in Hong Kong SAR and Macau SAR in the first half of 2026, representing a year-on-year increase of 285.83%, while revenue from the Japanese market reached RMB306 million, representing a year-on-year increase of 6.09%. Laomiao has 15 stores in Hong Kong SAR, Macau SAR, overseas markets and duty-free channels. Club Med has also continued to expand its global footprint, with Club Med Urban Oasis Hangzhou Longwu already open and Club Med South Africa Beach & Safari now in soft opening. Leveraging Fosun’s global ecosystem, Fidelidade in the insurance segment has expanded its business from Portugal to Portuguese-speaking countries and markets across Europe, Latin America, and Africa. Its international business now accounts for 26.7% of its consolidated total business, with continued growth in Portuguese-speaking countries. Meanwhile, Peak Reinsurance has maintained steady growth thanks to its global business footprint. The guiding principle behind Fosun’s globalization strategy is “Combining Global Resources with China’s Capabilities”, deeply integrating China’s manufacturing capabilities, service capabilities, and innovation dividends, with global markets. Starting with leveraging China’s growth momentum to establish its business presence, and progressing to a two-way engagement of “mutual empowerment between China and the world”, Fosun has now entered the 3.0 phase of “global organization + local operations”. In this phase, Fosun “truly operates with a global perspective”, having developed the ability to foster cross-regional, cross-cultural, and cross-organizational synergies within its business ecosystem and support the continued growth of its overseas revenue. At the interim results presentation held on 28 August, Guo Guangchang said: “Fosun’s future development goal is to ‘spur the horse to full speed’. We have already positioned ourselves on a trajectory of steady growth. Going forward, we will continue to advance innovation-driven and global development in industries where we have established competitive advantages, building on our momentum and accelerating further.”
- Circus SECircus Rolls Out Circus Pods: World's First Intelligent Refill System for Autonomous Sustainment RoboticsMUNICH, August 28, 2026--Circus SE (WKN: A2YN35 / ISIN: DE000A2YN355 / XETRA: CA1) today announces the commercial launch of Circus Pods, a standardized ingredient and supply chain infrastructure developed specifically for the company's autonomous sustainment robotic systems, for both defence and commercial use.
- Modern Dental Group Announces 2026 Interim ResultsRESULTS HIGHLIGHTS: - The Revenue for the six months ended 30 June 2026 was approximately HK$2,032.5 million, representing an increase of approximately 10.8% as compared to the same period in 2025. The growth in revenue was primarily attributable to the continued organic growth of the Group—driven by the accelerating adoption of digitalization across the global dental industry, particularly in Europe and Australia—alongside the stabilization and operational turnaround of the Mainland China market. This expansion was partially offset by a revenue decline in North America, which was impacted by a softer macroeconomic environment affecting high-value discretionary procedures, as well as management’s strategic decision to rationalize loss-making Dental Service Organization (DSO) accounts to optimize customer mix and protect margins. - The Gross Profit Margin for the six months ended 30 June 2026 was approximately 58.1%; the gross profit was approximately HK$1,180.9 million, reflecting an increase of approximately 17.4% as compared to the same period in 2025. - The Group’s EBITDA for the six months ended 30 June 2026 was approximately HK$ 560.7 million, representing an increase of approximately 22.8% as compared to the same period in 2025. - The Group’s Net Profit for the six months ended 30 June 2026 was approximately HK$ 377.6 million, representing an increase of 30.8% as compared to the same period in 2025. - Basic earnings per share for the six months ended 30 June 2026 amounted to HK40.07 cents, representing an increase of approximately 31.9% as compared to the same period in 2025. - The Board declared an interim dividend of HK14.0 cents per ordinary share for the six months ended 30 June 2026. ADDITIONAL HIGHLIGHTS: - For the six months ended 30 June 2026, the Group’s digital solution cases that are produced from its Mainland China, Thailand and Vietnam production facilities increased to approximately 627,773 cases, reflecting an increase of 29.2% as compared with the same period in 2025 as a result of our clients’ continued adoption of intra-oral scanners. HONG KONG, August 28, 2026 - 27 August 2026, Modern Dental Group Limited (“Modern Dental” or “the Group”, stock code: 03600.HK), a leading global dental prosthetic device provider, is pleased to announce the unaudited interim results for the six months ended 30 June, 2026 (“the Period”). In the first half of 2026, the global macroeconomic environment remains uncertain, with geopolitical tensions and potential tariff changes continuing to create headwinds. However, the Group’s geographically diversified production footprint and global distribution network position us strongly to navigate these challenges. Unlike many competitors reliant on single-country manufacturing, our operations across China, Vietnam and Thailand (including the newly acquired Hexa Ceram) provide superior resilience and flexibility. This strategy, combined with our ability to adapt quickly to local market conditions, enables the Group to mitigate risks and capitalise on opportunities across regions. The dental industry has continued to demonstrate remarkable resilience, underpinned by irreversible demographic trends, including aging populations and increasing awareness of oral health, which drive consistent long-term demand. Building on our well performance, the Group is well placed to sustain momentum and further strengthen its market leadership. Digitalisation remains an irreversible industry trend that is accelerating consolidation of the dental prosthetics industry. We are at the forefront of this transformation, with digital solution cases now representing approximately 35–43% of total volume. Our centralized digital workflows, intra-oral scanner partnerships, proprietary solutions and global education centers have enhanced operational efficiency, reduced turnaround times and delivers superior customer experiences. These initiatives create high entry barriers and will continue to drive margin expansion and market share gains in the coming years. European Businesses During the period under review, the European market recorded a revenue of approximately HK$1,093.3 million, representing an increase of approximately HK$173.0 million as compared with the six months ended 30 June 2025. This geographic market accounted for approximately 53.8% of the Group’s total revenue. The increase of revenue from the European market was attributable to the increase in sales order volume driven by the launch of new products, such as digital dentures, and our state-of-the-art digital workflows. North American Businesses During the period under review, the North American market recorded a revenue of approximately HK$331.3 million, representing a decrease of approximately HK$34.4 million as compared with the six months ended 30 June 2025. This geographic market accounted for approximately 16.3% of the Group’s total revenue. The top-line contraction in North America was primarily driven by a softer macroeconomic environment, which temporarily weighed on consumer sentiment and demand for high-value discretionary cosmetic procedures. In response, management proactively initiated a strategic rationalization of loss-making Dental Service Organization (DSO) accounts aimed at optimizing the customer mix, protecting gross margins, and focusing resources on higher-margin accounts. Concurrently, the Group’s diversified production footprint across the US, China, Vietnam, and Thailand continues to afford significant supply chain agility to navigate trade and tariff complexities—a key differentiator in the market. Demonstrating the resilience of this strategy, our US import business unit delivered a 1.4% period-on-period sales growth in the first half of 2026. This performance underscores how the accelerating trend toward clinical digitalization and the cost-competitiveness of our imported product lines have effectively mitigated and offset the impact of US tariffs. Greater China Businesses During the period under review, the Greater China market recorded a revenue of approximately HK$300.0 million, representing an increase of approximately HK$6.8 million as compared with six months ended 30 June 2025. This geographic market accounted for approximately 14.8% of the Group’s total revenue. Regional performance reflected diverging market dynamics across territories. In local currency terms, sales in Mainland China increased by approximately 0.9% year-on-year, signalling that the market has largely bottomed out from the initial impact of Volume-Based Procurement (VBP) policies and prolonged price competition. To protect sustainable profitability, the Group deliberately pivoted away from low-margin segments to focus on serving mid- to high-value customers. Conversely, sales in the Hong Kong market decreased by approximately 8.5% in local currency year-on-year. This contraction was primarily driven by a temporary reduction in local patient visits, as cross-border dental consumption increased due to aggressive promotions for dental treatments offered by Mainland China clinics targeting Hong Kong residents. Despite these near-term shifts, the Group remains optimistic about the mid- to long-term outlook for the Greater China region. Government procurement measures in Mainland China are expected to standardize prosthetic pricing and enhance market transparency, creating a more level playing field where the Group’s leading brand reputation, production scale, and operational efficiency serve as distinct competitive advantages. To capture evolving market demand, the Group is actively expanding its product portfolio, particularly in mid-end offerings and products. Australian Businesses During the period under review, the Australian market recorded a revenue of approximately HK$162.8 million, representing an increase of approximately HK$24.9 million as compared with the six months ended 30 June 2025. This geographic market accounted for approximately 8.0% of the Group’s total revenue. The increase in revenue from Australia was primarily driven by strong adoption of digital dental products and anti-snoring devices, and wins in dental service organization (DSO) customers. Other Markets Other markets primarily include Indian Ocean countries, Malaysia, Taiwan, Singapore and Thailand. For the six months ended 30 June 2026, these markets recorded a revenue of approximately HK$145.2 million, representing an increase of approximately HK$27.4 million as compared with the six months ended 30 June 2025. This geographic market accounted for approximately 7.1% of the Group’s total revenue. The increase in revenue from Other markets was primarily driven by the strong revenue contributions from Thailand, Singapore and Malaysia. The scaled manufacturing hubs in Thailand and Vietnam have enhanced regional supply efficiency, broadened product availability, and strengthened the Group’s competitive footprint in the region. Future Prospects and Strategies Looking ahead, the Group remains committed to reinforcing its worldwide leading position through a multi-dimensional approach. We will continue to pursue selective acquisitions, joint ventures and partnerships to expand and complement our product offerings, particularly in our high-growth clear aligner, Trioclear, while strengthening our distribution and sales networks. Ongoing investments in mass-scale production facilities, AI, automation, research and development, and digital innovation will drive efficiency gains and secure our position at the forefront of the industry. With the Board’s extensive experience and prudent governance, the Group is well positioned to seize new business opportunities while remaining strict financial discipline to safeguard Shareholders’ interests. The Board expresses its sincere gratitude to our dedicated employees, loyal customers, suppliers, and business partners for their unwavering commitment. Their collective efforts have been instrumental in delivering another year of record results and will continue to support the Group’s long-term success. About Modern Dental Group Modern Dental Group Limited (Stock code: 03600.HK) is a leading global dental prosthetics provider, distributor and consultant with a focus on providing custom-made prostheses to customers in the growing prosthetics industry. Our product portfolio is broadly categorized into three product lines: fixed prosthetic devices, such as crowns and bridges; removable prosthetic devices, such as removable dentures; and other devices, such as orthodontic devices, sports guards, clear aligners, and anti-snoring devices. Modern Dental Group has a global portfolio of respected brands, including Labocast, Permadental and Elysee Dental in Western Europe, YZJ Dental in China, Modern Dental Lab in Hong Kong, Modern Dental USA and MicroDental in the United States, Modern Dental Pacific in Australia and New Zealand, Modern Dental SG in Singapore, Modern Dental TW in Taiwan, Apex Digital Dental in Malaysia and Hexa Ceram in Thailand. We have grown these brands by providing premium and consistent quality products and superior customer service. We have more than 80 service centers in over 30 countries and serve over 35,000 customers.
- OracleOracle Named a Leader in the 2026 Gartner® Magic Quadrant™ for Supply Chain Management SuitesCompanies: Oracle CorporationOracle has been named a Leader in the 2026 Gartner® Magic Quadrant™ for Supply Chain Management Suites for Oracle Fusion Cloud Supply Chain &...
- Priority Courier ExpertsPriority Courier Experts Acquires INPAX, Expanding into the SoutheastMINNEAPOLIS, August 27, 2026--Priority Courier Experts, a leading provider of same-day logistics services, has acquired INPAX Shipping Solutions